Diagnosing emerging and reemerging infectious diseases: The pivotal role of the pathologist

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 1, 2011, Pages 83-91

  Olano, Juan P ^a   Walker, David H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARTICLE; BIOLOGICAL WARFARE; BIOSURVEILLANCE; CLASSIFICATION; COMMUNICABLE DISEASE; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; MICROBIOLOGY; MOLECULAR DIAGNOSIS; NANOTECHNOLOGY; UNITED STATES; VIROLOGY;

BIOSURVEILLANCE; BIOTERRORISM; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HUMANS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOTECHNOLOGY; NUCLEIC ACIDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79251611481     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis. 1995; 1 (1): 7-15.
2. Shugart HH. Factors influencing geographic distribution and incidence of tropical infectious diseases. In: Guerrant RL, Walker DH, Weiler PF, eds. Tropical Infectious Diseases. Principles, Pathogens and Practice. Vol 1. Philadelphia, PA: Churchill Livingstone, Elsevier; 2006: 13-18.
3. Satcher D. Emerging infections: getting ahead of the curve. Emerg Infect Dis. 1995; 1 (1): 1-6.
4. Nolte FS, Caliendo AM. Molecular detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA eds. Manual of Clinical Microbiology. Vol. 1. Washington, DC: ASM Press; 2007: 218-244.
5. Wolk D, Mitchell S, Patel R. Principles of molecular microbiology testing methods. Infect Dis Clin North Am. 2001; 15 (4): 1157-1204.
6. Holland CA. FDA-cleared/approved molecular diagnostic tests. Association for Molecular Pathology. Document listed in "Publications & Resources" at http://www.amp.org/. Accessed August 23, 2010.
7. Persing DH, Tenover FC, Versalovic J, Tang YW, Unger E, Relman DA. Molecular Microbiology: Principles and Practice. Washington, DC: ASM Press; 2004.
8. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N Engl J Med. 1990; 323 (23): 1573-1580.
9. Hjelle B, Jenison S, Torrez-Martinez N, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol. 1994; 68 (2): 592-596.
10. Relman DA, Falkow S. Identification of uncultured microorganisms: expanding the spectrum of characterized microbial pathogens. Infect Agents Dis. 1992; 1 (5): 245-253.
11. Relman DA. Emerging infections and newly-recognised pathogens. Neth J Med. 1997; 50 (5): 216-220.
12. Relman DA. Detection and identification of previously unrecognized microbial pathogens. Emerg Infect Dis. 1998; 4 (3): 382-389.
13. Loeffelholz MJ. Solid and liquid phase array technologies. In: Persing D, Tenover F, Versalovic J, Tang YW, Unger ER, Relman DA, White TJ, eds. Molecular Microbiology: Diagnostic Principles and Practice. Washington, DC: ASM Press; 2004: 281-284.
14. Miller MB, Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev. 2009; 22 (4): 611633.
15. Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010; 23 (1): 235-251.
16. Ling MM, Ricks C, Lea P. Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev Mol Diagn. 2007; 7 (1): 87-98.
17. Procop GW. Molecular diagnostics for the detection and characterization of microbial pathogens. Clin Infect Dis. 2007; 45 (suppl 2): S99-S111.
18. Smith PL, WalkerPeach CR, Fulton RJ, DuBois DB. A rapid, sensitive, multiplexed assay for detection of viral nucleic acids using the FlowMetrix system. Clin Chem. 1998; 44 (9): 2054-2056.
19. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation. 1999; 68 (9): 1305-1311.
20. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996; 272 (5265): 1167-1170.
21. Reid R, Greenberg M, Jenson AB, et al. Sexually transmitted papillomaviral infections, I: the anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol. 1987, 156 (1): 212-222.
22. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis. 1997; 175 (4): 814820.
23. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998; 339 (21): 1485-1492.
24. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med. 1996; 2 (6): 625-629.
25. Baron EJ. Implications of new technology for infectious diseases practice. Clin Infect Dis. 2006; 43 (10): 1318-1323.
26. Mikhailovich V, Gryadunov D, Kolchinsky A, Makarov AA, Zasedatelev A. DNA microarrays in the clinic: infectious diseases. Bioessays. 2008; 30 (7): 673682.
27. Millar BC, Xu J, Moore JE. Molecular diagnostics of medically important bacterial infections. Curr Issues Mol Biol. 2007; 9 (1): 21-39.
28. Aragon LM, Navarro F, Heiser V, Garrigo M, Espanol M, Coll P. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. ) Antimicrob Chemother. 2006; 57 (5): 825-831.
29. Monecke S, Ehricht R. Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect. 2005; 11 (10): 825-833.
30. Sintchenko V, Gallego B. Laboratory-guided detection of disease outbreaks: three generations of surveillance systems. Arch Pathol Lab Med. 2009; 133 (6): 916-925.
31. Panackal AA, M'Ikanatha N M, Tsui FC, et al. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis. 2002; 8 (7): 685-691.
32. Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA. 1999; 282 (19): 1845-1850.
33. Bravata DM, McDonald KM, Smith WM, et al. Systematic review: surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med. 2004; 140 (11): 910-922.
34. Lewis MD, Pavlin JA, Mansfield JL, et al. Disease outbreak detection system using syndromic data in the greater Washington DC area. Am J Prev Med. 2002; 23 (3): 180-186.
35. Wang L, Ramoni MF, Mandl KD, Sebastiani P. Factors affecting automated syndromic surveillance. Artif Intell Med. 2005; 34 (3): 269-278.
36. Berger M, Shiau R, Weintraub JM. Review of syndromic surveillance: implications for waterborne disease detection. J Epidemiol Community Health. 2006; 60 (6): 543-550.
37. Buehler JW, Hopkins RS, Overhage JM, Sosin DM, Tong V. Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group. MMWR Recomm Rep. 2004; 53 (RR05); 1-11.
38. Weber SG, Pitrak D. Accuracy of a local surveillance system for early detection of emerging infectious disease. JAMA. 2003; 290 (5): 596-598.
39. Hedberg CW, Besser JM. Commentary: cluster evaluation, PulseNet, and public health practice. Foodborne Pathog Dis. 2006; 3 (1): 32-35.
40. Monecke S, Berger-Bachi B, Coombs G, et al. Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin. Clin Microbiol Infect. 2007; 13 (3): 236249.
41. Mellmann A, Friedrich AW, Rosenkotter N, et al. Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med. 2006; 3 (3): e33.
42. Urwin R, Maiden MC. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 2003; 11 (10): 479-487.
43. Casadevall A, Relman DA. Microbial threat lists: obstacles in the quest for biosecurity? Nat Rev Microbiol. 2010; 8 (2): 149-154.
44. Reis BY, Kirby C, Hadden LE, et al. AEGIS: a robust and scalable real-time public health surveillance system. J Am Med Inform Assoc. 2007; 14 (5): 581-588.
45. O'Connor MJ, Buckeridge DL, Choy M, Crubezy M, Pincus Z, Musen MA. BioSTORM: a system for automated surveillance of diverse data sources. AMIA Annu Symp Proc. 2003: 1071.
46. Layne SP, Beugelsdijk TJ. Laboratory firepower for infectious disease research. Nat Biotechnol. 1998; 16: 825-829.
47. Heymann DL, Rodier GR. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Infect Dis. 2001; 1 (5): 345-353.
48. Johnson CJ, Zhukovsky N, Cass AE, Nagy JM. Proteomics, nanotechnology and molecular diagnostics. Proteomics. 2008; 8 (4): 715-730.
49. Taniguchi N. On the basic concept of nano-technology. Proc Intl Conf Prod Eng. Tokyo, Japan, Part II: Japan Society of Precision Engineering; 1974.
50. Drexler E. Nanosystems: Molecular Machinery and Manufacturing with Applications to Computation [dissertation]. Cambridge: Massachussets Institute of Technology; September 1991.
51. Binnig G, Rohrer H. Scanning tunneling microscopy. IBM J Res Dev. 1986; 30 (4): 355.
52. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991; 354: 56-58.
53. 60 : buckminsterfullerene. Nature. 1985; 318: 162-163.
54. Amato I. Atomic imaging: candid cameras for the nanoworld. Science. 1997; 276 (5321): 1982-1985.
55. Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin Chem. 2007; 53 (11): 2002-2009.
56. Radwan SH, Azzazy HM. Gold nanoparticles for molecular diagnostics. Expert Rev Mol Diagn. 2009; 9 (5): 511-524.
57. Alivisatos AP, Johnsson KP, Peng X, et al. Organization of 'nanocrystal molecules' using DNA. Nature. 1996; 382 (6592): 609-611.
58. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998; 281 (5385): 20132016.
59. Hotz CZ. Applications of quantum dots in biology: an overview. Methods Mol Biol. 2005; 303: 1-17.
60. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005; 307 (5709): 538-544.